摘要
我们先前的子宫内膜异位症全基因组表达分析法表明,10-11转基因的失调(Tet1,TET2,和TET3)参与转换5 -甲基胞嘧啶到5 -羟甲基胞嘧啶(5-hmC)。本次研究的目的是验证子宫内膜在异位和正位中TET基因的表达,体外蜕膜过程中人子宫内膜间质成纤维细胞的原代培养,以及量化子宫内膜异位症患者的 5-hmC 水平。在妇科手术时,血液,子宫内膜正位以及子宫内膜组织被收集。在有或者无子宫内膜异位妇女的体内膜中制造出母细胞,并在体外蜕膜中执行。血液和组织中的基因组DNA使用酶联免疫吸附法对5-hmC绝对量化。在子宫内膜异位症中,TET1,TET2和TET3的表达相比较非子宫内膜异位症对体内膜的控制降低了。令人惊讶的是,5-hmC 在异位内膜的总量比控制正位子宫内膜更高,而相比非子宫内膜异位症的妇女,子宫内膜异位症患者血液基因组DNA中含有明显更少的5-hmc。TET1,TET2和TET3的表达在非蜕膜HESFENDO中减少了。在体外蜕膜中,控制HESF体现了TET3表达的减少,然而蜕膜的HESF-ENDO在表达TET1,TET2和TET3时并没有很大数据上的变化。这些结果表明TET基因在异位内膜和在HESF-ENDO中有所下调,并且第一次暗示了TET基因在子宫内膜异位症中所起的作用。在异位内膜组织中,5-hmc很高的总量表明,这些组织有独特的外在调节。
关键词: 5-羟甲基胞嘧啶(5-hmC),子宫内膜异位症,表观遗传修饰,母细胞(子宫内膜间质成纤维细胞),在体外蜕膜化,TET(10-11转)基因。
Current Molecular Medicine
Title:Ten-Eleven Translocation Genes are Downregulated in Endometriosis
Volume: 16 Issue: 3
Author(s): F.J. Roca, H.A. Loomans, A.T. Wittman, C.J. Creighton and S.M. Hawkins
Affiliation:
关键词: 5-羟甲基胞嘧啶(5-hmC),子宫内膜异位症,表观遗传修饰,母细胞(子宫内膜间质成纤维细胞),在体外蜕膜化,TET(10-11转)基因。
摘要: Our previous whole genome expression analysis of endometriomas suggested dysregulation of the ten-eleven translocation genes (TET1, TET2, and TET3), involved in converting 5- methylcytosine to 5-hydroxymethylcytosine (5-hmC). The objective of this study was to validate the expression of TET genes in ectopic and eutopic endometrium and in primary cultures of human endometrial stromal fibroblasts (HESF) during in vitro decidualization and to quantify 5-hmC levels in patients with endometriosis. Blood, eutopic endometrium, and endometriotic tissues were collected at time of gynecologic surgery. HESF cultures were created from eutopic endometrium of women without (HESF-CONTROL) and with endometriosis (HESF-ENDO) and underwent in vitro decidualization. Genomic DNA from blood and tissues underwent quantification of the absolute amount of 5-hmC using ELISA. The expression of TET1, TET2, and TET3 was decreased in endometriosis compared to non-endometriosis control eutopic endometrium. Surprisingly, the global amount of 5-hmC was higher in ectopic endometrium than control eutopic endometrium, while genomic DNA from blood of women with endometriosis contained statistically significantly less 5-hmC than women without endometriosis. Expression of TET1, TET2, and TET3 was decreased in non-decidualized HESFENDO. Upon in vitro decidualization, control HESF showed decreased expression of TET3, while decidualized HESF-ENDO showed no statistically significant change in expression of TET1, TET2, or TET3. These results indicate that the TET genes are downregulated in ectopic endometrium and in HESF-ENDO, and suggest for the first time that TET genes play a role in endometriosis. High global amounts of 5-hmC in endometriotic tissues suggest unique epigenetic regulation in these tissues.
Export Options
About this article
Cite this article as:
F.J. Roca, H.A. Loomans, A.T. Wittman, C.J. Creighton and S.M. Hawkins , Ten-Eleven Translocation Genes are Downregulated in Endometriosis, Current Molecular Medicine 2016; 16 (3) . https://dx.doi.org/10.2174/1566524016666160225153844
DOI https://dx.doi.org/10.2174/1566524016666160225153844 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers